73.3 F
Providence
Thursday, October 1, 2020
Home Tags Rubius Therapeutics

Tag: Rubius Therapeutics

PROVIDENCE BUSINESS NEWS has announced that 66 companies will be recognized in its 2020 Best Places to Work program.

PBN announces 2020 Best Places to Work honorees

PROVIDENCE – Providence Business News has announced 66 honorees for its 2020 Best Places to Work program. Each of the companies recognized for this year’s...
RUBIUS THERAPEUTICS reported a loss of $48.5 million in the first quarter of 2020.

Rubius Therapeutics posts $48.5M loss in Q1; prioritizes on oncology and...

CAMBRIDGE, Mass. – Rubius Therapeutics Inc. posted a loss of $48.5 million for the first quarter of 2020, or a loss of 60 cents...
RUBIUS THERAPEUTICS spent $163.5 million in 2019. The company does not yet generate revenue.

Rubius Therapeutics reports $163.5M loss in 2019; focuses on oncology and...

PROVIDENCE – Rubius Therapeutics Inc. reported a year-end loss of $163.5 million in 2019, an increase from $89.2 million in 2018. Loss per diluted share...
RUBIUS THERAPEUTICS reported a loss of $47 million in the third quarter.

Rubius Therapeutics posts $47M loss in Q3 on increase in R&D...

CAMBRIDGE, Mass. - Rubius Therapeutics Inc. reported a loss of $47 million in the third quarter, or 59 cents per diluted share, the company...
RUBIUS THERAPEUTICS reported a loss of $39.4 million in the second quarter of 2019. The company has yet to record revenue..4 million in the second quarter of 2019, The company is yet to have revenue.

Rubius reports $39.4M loss in Q2, heralds progress

PROVIDENCE – Rubius Therapeutics Inc. reported on Tuesday a loss of $39.4 million in the second quarter of 2019, or 50 cents per diluted...
BROADENED MISSION: Carol Malysz, executive director of Providence-based biotechnology trade association RI BIO, said the group has broadened its focus. Previously known as MedMates, this year the company changed its name and approach to promote the entire biotech industry.
 / PBN PHOTO/MICHAEL SALERNO

Ocean State starting to see growth in biotech industry

RI BIO, a Providence-based biotechnology trade association, is on a mission to put Rhode Island on the biotech industry’s map. Despite the state having...

Rubius announces 3 new patents for cellular-therapy program

PROVIDENCE – Rubius Therapeutics, a Cambridge, Mass.-based biotech firm that develops and genetically engineers red blood cells for use in medications for rare diseases,...
RUBIUS THERAPEUTICS reported a $32.6 million loss in the first quarter of 2019.

Rubius Therapeutics reports $32.6M loss in Q1

SMITHFIELD – Rubius Therapeutics Inc. reported a net loss of $32.6 million in the first quarter of 2019, or 42 cents per diluted share,...

Rubius appoints Holles to board, Whitehead as SVP, chief quality officer

PROVIDENCE – Rubius Therapeutics Inc. has appointed Natalie Holles to its board of directors and Greg Whitehead as senior vice president and chief quality...

Rubius Therapeutics added to Nasdaq biotechnology index

SMITHFIELD – Biotechnology firm Rubius Therapeutics Inc. was added to the Nasdaq biotechnology index on Dec. 24. The company, based in Cambridge, Mass., but building...

Stay up to date with PBN's Morning Call & Daily Edition newsletters.

- Featured Event -

Latest News

Subscribe with Providence Business News to keep reading.

We’re glad you are enjoying PBN.

PBN is back in print.

Hide